NASDAQ: FLGCFlora Growth Corp Stock
$0.29+0.04 (+16%)
Updated Mar 31, 2023
FLGC Price
$0.29
Fair Value Price
N/A
Market Cap
$22.75M
52 Week Low
$0.19
52 Week High
$1.90
P/E
N/A
P/B
0.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.35
Operating Cash Flow
N/A
Beta
1.82
Next Earnings
Apr 3, 2023
Ex-Dividend
N/A
Next Dividend
N/A
FLGC Overview
Flora Growth Corp. offers medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies in the U.S. and internationally. Flora Growth sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth was incorporated in 2019 and is headquartered in Toronto, Ontario, Canada.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FLGC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FLGC is good value based on its book value relative to its share price (0.42x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.83x)
P/B vs Industry Valuation
FLGC's short-term assets ($22.91M) exceed its short-term liabilities ($8.68M)
Short-term Liabilities Financials
FLGC's short-term assets ($22.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more FLGC due diligence checks available for Premium users.
Be the first to know about important FLGC news, forecast changes, insider trades & much more!
FLGC News
Valuation
FLGC fair value
Fair Value of FLGC stock based on Discounted Cash Flow (DCF)
Price
$0.29
Fair Value
$0.46
Undervalued by
36.54%
FLGC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
18.12x
Market
22.13x
FLGC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
1.83x
FLGC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FLGC's financial health
Profit margin
Revenue
$10.8M
Net Income
-$7.4M
Profit Margin
-68.6%
Assets to liabilities
Assets
$73.1M
Liabilities
$19.0M
Debt to equity
0.35
FLGC's short-term assets ($22.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FLGC's short-term assets ($22.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FLGC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.3M
Investing
-$157.0k
Financing
-$415.0k
FLGC vs Pharmaceutical Stocks
Flora Growth Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.